(Q40218728)

18 September 2017

Sex hormones, vascular function and the outcome of hormone replacement therapy in cardiovascular disease (English)

1 reference

Hormone Replacement Therapy

18 September 2017

1 reference

Raouf A Khalil

1

1 reference

18 September 2017

1 May 2007

1 reference

18 September 2017

1 reference

18 September 2017

3

1 reference

18 September 2017

3

1 reference

18 September 2017

283-300

1 reference

Review of the American Heart Association's guidelines for cardiovascular disease prevention in women

18 September 2017

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Hypertension: trends in prevalence, incidence, and control

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Coronary artery disease: new insights into the pathophysiology, prevalence, and early detection of a monster menace.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Gender, sex hormones, and vascular tone

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Sex steroids, cardiovascular disease, and hypertension: unanswered questions and some speculations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Genomic and nongenomic effects of estrogen in the vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Molecular and cellular basis of cardiovascular gender differences

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Hormone replacement therapy and cardiovascular disease: what went wrong and where do we go from here?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Novel mechanisms responsible for postmenopausal hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Testosterone and coronary vascular tone: Implications in coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Epitope-dependent localization of estrogen receptor-alpha, but not -beta, in en face arterial endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Truncated estrogen receptor alpha 46-kDa isoform in human endothelial cells: relationship to acute activation of nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Differentially expressed messenger RNA isoforms of the human estrogen receptor-alpha gene are generated by alternative splicing and promoter usage

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Selective agonists of estrogen receptor isoforms: new perspectives for cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-alpha or estrogen receptor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Phytoestrogens inhibit growth and MAP kinase activity in human aortic smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

2-Methoxyestradiol, an estradiol metabolite, inhibits neointima formation and smooth muscle cell growth via double blockade of the cell cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Androgens are necessary for the development of fructose-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Estradiol alters nitric oxide production in the mouse aorta through the alpha-, but not beta-, estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Improvement of Endothelial Dysfunction by Selective Estrogen Receptor-α Stimulation in Ovariectomized SHR

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

ERbeta has nongenomic action in caveolae

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Evidence for a difference in nitric oxide biosynthesis between healthy women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

The isoflavone Equol mediates rapid vascular relaxation: Ca2+-independent activation of endothelial nitric-oxide synthase/Hsp90 involving ERK1/2 and Akt phosphorylation in human endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Progesterone antagonizes the vasoprotective effect of estrogen on antioxidant enzyme expression and function

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

COX-2-derived prostacyclin confers atheroprotection on female mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

17Beta-estradiol modulates endothelin-1 expression and release in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Estradiol metabolites inhibit endothelin synthesis by an estrogen receptor-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Ovarian hormones modulate endothelin-1 vascular reactivity and mRNA expression in DOCA-salt hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

17beta-estradiol downregulates tissue angiotensin-converting enzyme and ANG II type 1 receptor in female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Protein kinase C isoforms as specific targets for modulation of vascular smooth muscle function in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Nongenomic vasodilator action of progesterone on primate coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Hypertension and RhoA/Rho-kinase signaling in the vasculature: highlights from the recent literature

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Physiological role of ROCKs in the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Rho-kinase is an important therapeutic target in cardiovascular medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Evidence that estrogen suppresses rho-kinase function in the cerebral circulation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Estradiol enhances endothelial cell interactions with extracellular matrix proteins via an increase in integrin expression and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Conjugated equine estrogens alone, but not in combination with medroxyprogesterone acetate, inhibit aortic connective tissue remodeling after plasma lipid lowering in female monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

17beta-oestradiol enhances release of matrix metalloproteinase-2 from human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Estrogen attenuates vascular expression of inflammation associated genes and adhesion of monocytes to endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Tumor necrosis factor-alpha and vascular angiotensin II in estrogen-deficient rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Estrogen and progestagens differentially modulate vascular proinflammatory factors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Dihydrotestosterone decreases tumor necrosis factor-alpha and lipopolysaccharide-induced inflammatory response in human endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Perspectives on the Women's Health Initiative trial of hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Estrogen replacement therapy, atherosclerosis, and vascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Different effects of oral conjugated estrogen and transdermal estradiol on arterial stiffness and vascular inflammatory markers in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Estrogen receptor-alpha mediates acute myocardial protection in females

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Acute anti-ischemic effect of testosterone in men with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Estrogen and tamoxifen modulate cerebrovascular tone in ovariectomized female rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Raloxifene elicits combined rapid vasorelaxation and long-term anti-inflammatory actions in rat aorta.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Design and methods of the Raloxifene Use for The Heart (RUTH) study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Critical review of health effects of soyabean phyto-oestrogens in post-menopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Pharmacology of estrogens and progestogens: influence of different routes of administration

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.3.283

21 January 2018

Identifiers

DOI

10.2217/14796678.3.3.283

1 reference

18 September 2017

1 reference

PubMed ID

19804220